Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Obesity

Novo Nordisk cuts Wegovy prices, following similar move by Zepbound-maker Eli Lilly

Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance

The Independent UK

Is fatty liver in kids a bigger threat than we know? Could it lead to cirrhosis?

Childhood obesity is rising at an alarming rate, bringing with it a hidden but serious health concern—Pediatric Fatty Liver Disease (PFLD), now recognized as Metabolic Associated Fatty Liver Disease (MAFLD). Too frequently underdiagnosed, this disease can quietly advance to advanced liver damage, cirrhosis, and even liver failure if not treated.

The Times of India

Beyond blame: The role of malfunctioning fat tissue in the disease of obesity

Many people who have struggled with their weight have been told to “eat less and move more.” Others have spent years juggling trendy diets, from keto to fasting, with minimal results. Despite their best efforts, what they often hear from physicians, friends, family and even strangers, is that they lack…

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

A third of the world’s children will be obese or overweight in the next 25 years

More than half of adults will also be overweight or have obesity in the same timeframe, researchers say

The Independent UK

Slim is out, fat is in: Over half the world set to be overweight or obese by 2050; how it will impact health

The world is getting fatter by the day and in the next 25 years over half of us could be overweight or obese, a new study published in The Lancet journal has warned. Not that this can't be reversed, but it would demand a series of bold and drastic measures…

The Times of India

The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up

Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.

Fortune

Act Now: By 2050 Over Half Of Adults, A Third Of Children Will Be Obese

Researchers are calling for urgent action and global policy reforms to address widespread global obesity pandemic by 2050.

Medical Daily

Read news from The Economist, FT, and more,
with one subscription

Most adults, a third of children will be overweight or obese by 2050: Study

Lancet study uses data from 204 countries to paint a grim picture of what it called an ‘unprecedented global epidemic’.

Al Jazeera

World Obesity Day 2025: Theme, history and importance

Obesity has become one of the biggest health challenges worldwide, affecting millions of people across different age groups. But what exactly is obesity, and why is it such a pressing issue?

The Times of India

Without change, half of Australian kids and adolescents will be overweight or obese by 2050

Since the 1990s, the proportion of the world’s population who are overweight (with a body mass index of 25–30) or obese (with a body mass index of 30 or above) has doubled.

The Conversation

One in two Australian children will be obese or overweight by 2050 unless ‘action taken now’

Study predicts nation on course to have second-highest overweight and obesity rates in world but says urgent government reform could help avoid this

The Guardian - AU

More than half of adults worldwide will be overweight or obese by 2050 – report

Analysis forecasts a third of young people will also be overweight or obese, in ‘unparalleled’ threat to health

The Guardian - UK

Number of obese children and adults in the UK ‘will rise substantially by 2050’

Children as young as five face a future of growing obesity, according to a new report.

The Independent UK

Obesity in children under 14 set to rise by more than half by 2050, shocking research suggests

Experts said the global picture represents a ‘profound tragedy and a monumental societal failure’

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

We looked at what supermarkets in 97 countries are doing to our waistlines. Here’s what we found

In many countries, buying food at supermarkets, convenience stores and online has become the norm. But what’s the convenience of modern food shopping doing to our health?

The Times of India

The role of obesity in bone fractures: A growing concern for Indian seniors

Obesity is an increasing health concern among Indian elderly, with a variety of consequences, including an increased risk of bone fractures. While many individuals believe that having additional body weight provides better protection against fractures, medical evidence suggests otherwise. Obesity has a negative influence on bone health, making the elderly…

LiveScience

Scientists describe new type of fat in human bellies

Scientists have pinpointed and described unusual subtypes of fat cells that may help scientists explain why gut fat is linked to poor health. The research could open up new avenues for medical treatments.

Barchart

Is This Penny Stock’s 525% Upside Potential an Attainable Goal?

Skye Bioscience is trying to establish a presence in the weight-loss drug market.

Get all your
news in one place.

100's of premium titles.
One news app.

The Times of India

JAMA study says adopting THIS diet reduces risk of certain types of cancer

The Mediterranean diet has been hailed as one of the best forms of the diet. It supports heart health and has anti-cancer properties. Several studies have proved the effectiveness of the diet in women and elderly people, especially.

The Conversation

England subsidises drugs like Ozempic for weight loss. Could Australia follow?

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide) and Mounjaro (one of the brand names for tirzepatide).

StockNews.com

3 Pharmaceutical Stocks Betting Big on Weight Loss Drugs

Weight-loss drugs aren’t just slimming waists; they create a $100 billion market opportunity. With plenty up for grabs, pharmaceutical giants like Eli Lilly and Company (LLY), Novo Nordisk (NVO), and Amgen (AMGN) are betting big on next-generation weight loss treatments to dominate this booming market. Keeping reading.

The Times of India

As PM Modi starts anti-obesity campaign, doctor shares foods that can lead to weight gain

Many people do not realize the importance of a healthy diet in their weight loss journey until they encounter a few roadblocks. A healthy diet plays a big role in maintaining the weight along with keeping key parameters of the body like insulin, blood sugar level, obesity and other in…

The Independent UK

Supplies of high-demand obesity drugs are improving – but they’re not easier to get

‘There are a lot of people right now who want access to the medication and can’t get it’

Dynamite News

Mohanlal, Shreya Ghoshal, other influential figures join PM Modi's call to combat obesity with reduced oil consumption

In his latest effort to tackle rising health concerns, Prime Minister Narendra Modi has called for a nationwide movement to combat obesity and promote healthier eating habits Read further on Dynamite News:

The Times of India

Obesity is the root cause of many diseases: PM Narendra Modi nominates 10 celebs to spread awareness

As obesity remains a critical health issue, Prime Minister Narendra Modi has made a strong pitch in his monthly Mann Ki Baat radio broadcast.

1 … 20 21 22 23

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

the University of Washington

65 stories

Eli Lilly and Company

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.